title: Posttransplant Kaposi sarcoma and risk for deep venous thrombosis: a case-control study.
authors.forename: Rainer U
authors.initials: RU
authors.lastname: Pliquett
authors.forename: Helmut
authors.initials: H
authors.lastname: Schöfer
authors.forename: Aida
authors.initials: A
authors.lastname: Asbe-Vollkopf
authors.forename: Ingeborg A
authors.initials: IA
authors.lastname: Hauser
authors.forename: Ernst H
authors.initials: EH
authors.lastname: Scheuermann
authors.forename: Heinz-Georg
authors.initials: HG
authors.lastname: Kachel
mesh_terms: D000328:Adult; D065095:Calcineurin Inhibitors; D016022:Case-Control Studies; D005260:Female; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012306:Risk; D012514:Sarcoma, Kaposi / Q000150:complications* / Q000175:diagnosis*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000209:etiology*
chemical_list: D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D009173:Mycophenolic Acid; D011241:Prednisone